Interferon-β treatment alters peripheral blood monocytes chemokine production in MS patients

Journal of Neuroimmunology

Volumn 126, Issue 1-2, 2002, Pages 205-212

  Comabella, Manuel ^a   Imitola, Jaime ^a   Weiner, Howard L ^a   Khoury, Samia J ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chemokines; Interferon ; Monocytes; Multiple sclerosis

Indexed keywords

BETA INTERFERON; CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON BETA SERINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOKINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STAINING; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ADULT; CD40 LIGAND; CHEMOKINE CCL2; CHEMOKINES, CXC; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON-BETA; INTERLEUKIN-10; INTERLEUKIN-8; MALE; MONOCYTE CHEMOATTRACTANT PROTEINS; MONOCYTES; MULTIPLE SCLEROSIS; PYRIMIDINONES; T-LYMPHOCYTES; THIAZOLES;

EID: 0036095927     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00064-4     Document Type: Article

References (37)

1. Macrophage inflammatory protein-1 alpha activates basophils and mast cells
2. Activation of dual T cell signaling pathways by the chemokine RANTES
3. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines
4. CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
5. Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties
6. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β-1b
7. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies
8. The role of CD40 ligand in costimulation and T-cell activation
9. Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation
10. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b
11. Intramuscular interferon β-1a for disease progression in relapsing multiple sclerosis
12. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
13. Differential CC chemokine-induced enhancement of T helper cell cytokine production
14. Immunological mechanisms in multiple sclerosis
15. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines
16. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines
17. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts
18. Chemokines - Chemotactic cytokines that mediate inflammation
19. Differential induction of chemokines in human microglia by type I and II interferons
20. Macrophage inflammatory protein-1α in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases
21. Interferon β decreases T cell activation and interferon gamma production in multiple sclerosis
22. 2 type T-cell clone during the induction phase of anergy
23. Downregulation of interleukin 8 gene expression in human fibroblasts: Unique mechanism of transcriptional inhibition by interferon
24. Properties of the novel proinflammatory supergene "intercrine" cytokine family
25. Interferon β-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
26. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
27. Management of multiple sclerosis
28. In vivo effects of interferon β-1a on immunosuppressive cytokines in multiple sclerosis
29. Human macrophage inflammatory protein alpha (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes
30. Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity
31. Synthesis of the CC-chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response
32. CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
33. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
34. Increased numbers of CCR5+ interferon-γ- and tumor necrosis factor-α-secreting T lymphocytes in multiple sclerosis patients
35. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9
36. Chemokines and T lymphocyte activation: I. β chemokines costimulate human T lymphocyte activation in vitro
37. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1α by interferon-β